Novavax (NVAX) - Market capitalization

Market cap: $1.53 Billion USD

As of July 2026 Novavax has a market cap of $1.53 Billion USD. This makes Novavax the world's 5439th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2026

End of year Market Cap

Year	Marketcap	Change
2026	$1.53 B	38.23%
2025	$1.10 B	-16.32%
2024	$1.32 B	132.61%
2023	$0.57 B	-34.75%
2022	$0.87 B	-91.92%
2021	$10.81 B	52.38%
2020	$7.09 B	5413.03%
2019	$0.12 B	-81.8%
2018	$0.70 B	51.97%
2017	$0.46 B	36.2%
2016	$0.34 B	-84.91%
2015	$2.26 B	59.93%
2014	$1.41 B	32.57%
2013	$1.06 B	282.07%
2012	$0.27 B	93.02%
2011	$0.14 B	-46.31%
2010	$0.26 B	1.17%
2009	$0.26 B	104.01%
2008	$0.13 B	-36.63%
2007	$0.20 B	-18.57%
2006	$0.25 B	20.22%
2005	$0.21 B	63.42%
2004	$0.12 B	-38.1%
2003	$0.20 B	220.84%
2002	$64.92 M	-80.23%
2001	$0.32 B	74.82%
2000	$0.18 B	120.23%
1999	$85.31 M	262.89%
1998	$23.5 M	-60.86%
1997	$60.06 M	63.86%
1996	$36.65 M

End of Day market cap according to different sources

On Jul 10th, 2026 the market cap of Novavax was reported to be:

$1.53 Billion USD

by Nasdaq

$1.53 Billion USD

by CompaniesMarketCap

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Novartis NVS	$293.94 B	19,059.18%	🇨🇭 Switzerland
Pfizer PFE	$137.75 B	8,878.94%	🇺🇸 USA
AstraZeneca AZN	$266.14 B	17,247.46%	🇬🇧 UK
GSK plc GSK	$105.70 B	6,790.05%	🇬🇧 UK
Sarepta Therapeutics SRPT	$2.00 B	30.40%	🇺🇸 USA
Celldex Therapeutics CLDX	$3.06 B	100.09%	🇺🇸 USA
Agenus AGEN	$0.13 B	-90.91%	🇺🇸 USA
NanoViricides NNVC	$34.7 M	-97.74%	🇺🇸 USA
BioCryst Pharmaceuticals BCRX	$2.65 B	73.12%	🇺🇸 USA
Emergent BioSolutions EBS	$0.41 B	-72.93%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Market capitalization of Novavax (NVAX)

Market cap: $1.53 Billion USD